216095265	216095265	CD	B-NP	O
|	|	NN	I-NP	O
CKH	CKH	NN	I-NP	O
|	|	NN	I-NP	O
79004464	79004464	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
342923	342923	CD	B-NP	O
|	|	CC	I-NP	O
5/10/2001	5/10/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Fe	Fe	NNP	I-NP	O
deficient	deficient	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/7/2001	9/7/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/15/2001	4/15/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
LOXTERCAMP	LOXTERCAMP	NN	B-NP	O
,	,	,	O	O
RUFUS	RUFUS	NN	B-NP	O
405-36-85-7	405-36-85-7	CD	I-NP	O
Rouge	Rouge	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/2/01	2/2/01	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCBROWN	MCBROWN	NNP	B-NP	O
,	,	,	O	O
MARLIN	MARLIN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
VANCERIL	VANCERIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BECLOMETHASONE	BECLOMETHASONE	NNP	I-NP	O
DIPROPIONATE	DIPROPIONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
TID	TID	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FESO4	FESO4	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/3/01	10/3/01	CD	B-NP	O
by	by	IN	B-PP	O
BUFTON	BUFTON	NNP	B-NP	O
,	,	,	O	O
JOSIAH	JOSIAH	NNP	B-NP	O
NOLAN	NOLAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
52292481	52292481	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
,	,	,	O	O
INJ	INJ	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
REG	REG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAC	QAC	NNP	I-NP	O
&	&	CC	I-NP	O
HS	HS	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
>	>	SYM	B-NP	O
400	400	CD	I-NP	O
For	For	IN	B-PP	O
BS	BS	NN	B-NP	O
<	<	SYM	O	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
201	201	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
250	250	CD	B-NP	I-DNA
give	give	VB	B-VP	O
4	4	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
251	251	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
300	300	CD	B-NP	I-DNA
give	give	VB	B-VP	O
6	6	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	I-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
301	301	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
350	350	CD	B-NP	I-DNA
give	give	VB	B-VP	O
8	8	CD	B-NP	O
Units	Unit	NNS	I-NP	O
reg	reg	NN	B-NP	O
SC	SC	NN	I-NP	O
For	For	IN	B-PP	O
BS	BS	NNP	B-NP	O
from	from	IN	B-PP	O
351	351	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
400	400	CD	B-NP	I-DNA
give	give	VB	B-VP	O
10	10	CD	B-NP	O
Units	Units	NNP	I-NP	O
reg	reg	NN	I-NP	O
SC	SC	NNP	I-NP	O
MECLIZINE	MECLIZINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MECLIZINE	MECLIZINE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/30	5/30	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PRN	PRN	NN	I-NP	B-protein
dizziness	dizziness	NN	I-NP	I-protein
LOPRESSOR	LOPRESSOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METOPROLOL	METOPROLOL	NN	I-NP	I-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
5/30	5/30	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/01	10/3/01	CD	B-NP	O
by	by	IN	B-PP	O
ROCKWOOD	ROCKWOOD	NN	B-NP	O
,	,	,	O	O
FRANCES	FRANCES	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
willm	willm	NN	B-NP	O
otniro	otniro	NN	I-NP	O
INSULIN	INSULIN	NNP	B-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
HUMAN	HUMAN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
90	90	CD	I-NP	O
UNITS	UNITS	NNS	I-NP	O
qam	qam	NN	I-NP	O
;	;	:	O	O
45	45	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qpm	qpm	NN	I-NP	O
SC	SC	NN	I-NP	O
QAM	QAM	NN	I-NP	O
90	90	CD	B-NP	O
UNITS	UNITS	NNS	I-NP	O
qam	qam	NN	B-NP	O
45	45	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
qpm	qpm	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/30	5/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
TIAZAC	TIAZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
360	360	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/3/01	10/3/01	CD	B-NP	O
by	by	IN	B-PP	O
REYOLDS	REYOLDS	NNP	B-NP	O
,	,	,	O	O
GARFIELD	GARFIELD	NNP	B-NP	O
R	R	NNP	I-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
23338857	23338857	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
willm	willm	NN	B-NP	O
otniro	otniro	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/01	10/3/01	CD	B-NP	O
by	by	IN	B-PP	O
SERUM	SERUM	NNP	B-NP	O
,	,	,	O	O
EDISON	EDISON	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
,	,	,	I-NP	O
INJ	INJ	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TORSEMIDE	TORSEMIDE	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONIT	MONONIT	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
CARDIZEM	CARDIZEM	NN	I-NP	B-DNA
CD	CD	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
DILTIAZEM	DILTIAZEM	NN	I-NP	I-DNA
CD	CD	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
360	360	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/2/01	2/2/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
,	,	,	I-NP	O
INJ	INJ	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Barters	Barters	NNP	I-NP	O
10-14	10-14	CD	I-NP	O
DAYS	DAYS	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Trumbauer	Trumbauer	NNP	I-NP	O
2-3	2-3	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
Morphine	Morphine	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Fe	Fe	NNP	I-NP	O
deficient	deficient	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
OBESITY	OBESITY	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
Diastolic	Diastolic	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
atypical	atypical	JJ	I-NP	O
angina	angina	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
neg	neg	NN	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
4/4	4/4	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
angina	angina	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin-resistant	insulin-resistant	JJ	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitu	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
esophageal	esophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
Cr	Cr	NN	I-NP	O
1.4	1.4	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
tranfusion	tranfusion	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
acutely	acutely	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
70	70	CD	B-NP	O
yo	yo	NN	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
hisory	hisory	JJ	B-NP	O
off	off	IN	B-PP	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
diastolic	diastolic	JJ	B-ADJP	O
,	,	,	O	O
2-3	2-3	NN	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
70	70	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
,	,	,	O	O
CRI	CRI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
2.1-2	2.1-2	CD	I-NP	O
.9	.9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
T2DM	T2DM	NN	B-NP	O
,	,	,	O	O
Fe	Fe	NNP	B-NP	O
Def	Def	NNP	I-NP	O
Anemia	Anemia	NNP	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
two	two	CD	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
describes	describe	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
can	can	MD	B-VP	O
walk	walk	VB	I-VP	O
100	100	CD	B-NP	O
+	+	SYM	I-NP	O
feet	foot	NNS	I-NP	O
while	while	IN	B-SBAR	O
leaning	lean	VBG	B-VP	O
on	on	IN	B-PP	O
shopping	shopping	NN	B-NP	O
cart	cart	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
now	now	RB	B-ADVP	O
SOB	SOB	NN	B-NP	B-protein
with	with	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
30	30	CD	I-NP	O
feet	foot	NNS	I-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
PND	PND	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
three	three	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
gained	gain	VBN	I-VP	O
weight	weight	NN	B-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
records	record	NNS	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
daily	daily	RB	B-ADVP	O
BS	BS	NNP	B-NP	O
's	's	POS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
200-300	200-300	CD	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
daily	daily	JJ	B-NP	O
pressures	pressure	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
140	140	CD	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
F/Chills/Sweats	F/Chills/Sweat	NNPS	I-NP	B-protein
/	/	SYM	B-NP	B-protein
gustatory	gustatory	JJ	I-NP	I-protein
indulgences/Dysuria/BRBPR	indulgences/Dysuria/BRBPR	NN	I-NP	I-protein
/	/	SYM	B-NP	O
Melena	Melena	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
her	her	PRP$	B-NP	O
BM	BM	NN	I-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dark	dark	JJ	B-NP	O
brown	brown	NN	I-NP	O
and	and	CC	O	O
hard	hard	RB	B-ADVP	O
since	since	IN	B-PP	O
beginning	begin	VBG	B-VP	O
iron	iron	NN	B-NP	O
supp.s	supp.	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
room	room	NN	I-NP	O
spinning	spinning	NN	I-NP	O
,	,	,	O	O
beginning	begin	VBG	B-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
tinnitus/nausea/ha	tinnitus/nausea/ha	NN	I-NP	O
/	/	SYM	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
vision	vision	NN	B-NP	O
or	or	CC	I-NP	O
hearing	hearing	NN	I-NP	O
.	.	.	O	O

Sh	Sh	NNP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
numbness	numbness	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
some	some	DT	B-NP	O
unsteadiness	unsteadiness	NN	I-NP	O
of	of	IN	B-PP	O
gait	gait	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
a	a	DT	B-NP	O
cane	cane	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
FE	FE	NN	B-NP	O
def	def	NN	I-NP	O
Anemia	Anemia	NNP	I-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
neuropathy	neuropathy	NN	B-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
>	>	SYM	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
NLS1S2	NLS1S2	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
SM	SM	NNP	I-NP	O
--	--	:	O	O
>	>	NNP	B-NP	O
Axilla	Axilla	NNP	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
S4	S4	NN	I-NP	O
,	,	,	O	O
Lungs	Lung	NNS	B-NP	O
with	with	IN	B-PP	O
crakles	crakle	NNS	B-NP	O
one	one	CD	B-NP	O
half	half	JJ	I-NP	O
way	way	NN	I-NP	O
up	up	IN	B-ADVP	O
from	from	IN	B-PP	O
bases	base	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abd	Abd	NNP	B-NP	O
obese	obese	JJ	I-NP	O
NT	NT	NNP	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
R/M/G	R/M/G	NNP	I-NP	O
,	,	,	O	O
Ext	Ext	NNP	B-NP	O
wa	wa	NN	I-NP	O
rm	rm	NN	I-NP	O
,	,	,	O	O
+2	+2	CC	O	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
brawny	brawny	JJ	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
cranial	cranial	JJ	I-NP	O
nerves	nerve	NNS	I-NP	O
2-12	2-12	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
vibration	vibration	NN	I-NP	O
and	and	CC	I-NP	O
sensation	sensation	NN	I-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
,	,	,	O	O
position	position	NN	B-NP	O
sense	sense	NN	I-NP	O
preserved	preserve	VBN	B-VP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
K	K	NN	B-NP	O
3.6	3.6	CD	I-NP	O
Cr	Cr	NNP	I-NP	O
2.2	2.2	CD	I-NP	O
Hct	Hct	NNP	I-NP	O
27	27	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
9	9	CD	I-NP	O
Plat	Plat	NN	I-NP	O
395	395	CD	B-NP	O
INR	INR	NN	I-NP	O
1.2	1.2	CD	B-NP	O
Normal	Normal	JJ	I-NP	O
B12	B12	NN	I-NP	B-protein
and	and	CC	I-NP	O
folate	folate	NN	I-NP	O
in	in	IN	B-PP	O
3/5	3/5	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Fe	Fe	NN	B-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
TIBC	TIBC	NNP	B-NP	B-cell_line
314	314	CD	I-NP	I-cell_line
,	,	,	O	O
Ferritin	Ferritin	NN	B-NP	B-protein
31	31	CD	I-NP	I-protein
and	and	CC	O	O
Retics	Retic	NNS	B-NP	O
of	of	IN	B-PP	O
7.3	7.3	CD	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
failure	failure	NN	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
1st	1st	CD	B-NP	O
dgree	dgree	VBP	B-VP	O
AV	AV	NN	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
STTW	STTW	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
pt	pt	NN	I-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
PRBCs	PRBC	NNS	I-NP	B-cell_type
with	with	IN	B-PP	O
HCT	HCT	NN	B-NP	B-DNA
27	27	CD	I-NP	I-DNA
--	--	:	O	O
>	>	SYM	O	O
31	31	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
100	100	CD	B-NP	O
IV	IV	CD	I-NP	O
lasix	lasix	CD	I-NP	O
and	and	CC	O	O
diuresed	diurese	VBN	B-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
one	one	CD	I-NP	O
liter	liter	NN	I-NP	O
O/N	O/N	NN	I-NP	O
she	she	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
respiratory	respiratory	JJ	I-NP	O
fxn	fxn	NN	I-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
Illinois	Illinois	NNP	I-NP	O
without	without	IN	B-PP	O
distress	distress	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clearer	clear	JJR	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
JVD	JVD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
256	256	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BS	BS	NNP	I-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
213	213	CD	B-NP	O
,	,	,	I-NP	O
109	109	CD	I-NP	O
and	and	CC	I-NP	O
237	237	CD	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ADA	ADA	NN	I-NP	O
1800	1800	CD	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
85A	85A	NN	B-NP	O
and	and	CC	O	O
40P	40P	NN	B-NP	O
70/30	70/30	CD	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP	B-NP	O
70/30	70/30	CD	I-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
and	and	CC	I-NP	O
45	45	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
meclizine	meclizine	NN	B-NP	O
PRN	PRN	NN	I-NP	O
for	for	IN	B-PP	O
BPV	BPV	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
dc	dc	NN	I-NP	O
crit	crit	NN	I-NP	O
was	be	VBD	B-VP	O
30.6	30.6	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Gene	Gene	NNP	B-NP	O
Hettwer	Hettwer	NNP	I-NP	O
from	from	IN	B-PP	O
GI	GI	NNP	B-NP	O
who	who	WP	B-NP	O
suggested	suggest	VBD	B-VP	O
she	she	PRP	B-NP	O
be	be	VB	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
followthru	followthru	NN	I-NP	O
,	,	,	O	O
becaus	becaus	IN	B-PP	O
e	e	NN	B-NP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
EGD	EGD	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
already	already	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
anemia	anemia	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Standafer	Standafer	NNP	I-NP	O
at	at	IN	B-PP	O
Ibrook	Ibrook	NNP	B-NP	O
N	N	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
capsular	capsular	JJ	I-NP	O
camera	camera	NN	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-NP	O
weigh	weigh	VBP	B-VP	O
yourself	yourself	PRP	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
changes	change	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
pounds	pound	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
call	call	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Cubie	Cubie	NNP	I-NP	O
office	office	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
can	can	MD	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
the	the	DT	B-NP	O
excess	excess	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
please	please	VB	B-VP	O
drink	drink	VB	I-VP	O
diabetic	diabetic	JJ	B-NP	O
beverages	beverage	NNS	I-NP	O
and	and	CC	O	O
limit	limit	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
to	to	TO	B-PP	O
8-10	8-10	CD	B-NP	O
glasses	glass	NNS	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
gastroenterologists	gastroenterologist	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SEHORN	SEHORN	NNP	B-NP	O
,	,	,	O	O
KENNETH	KENNETH	NNP	B-NP	O
KENDRICK	KENDRICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WE48	WE48	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/2/01	2/2/01	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

